ADRA2A and small cell osteogenic sarcoma: In contrast, ADRA2A, CFD, MT3, NGFR, NTN1, OSCAR, PRRX2, SPP1, TP53I11, and WFDC1 were statistically upregulated in human Sertoli cells of SCOS patients compared to OA patients (Fig. 3b).